Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities

The advent of stem cell-derived cerebral organoids has already advanced our understanding of disease mechanisms in neurological diseases. Despite this, many remain without effective treatments, resulting in significant personal and societal health burden. Antisense oligonucleotides (ASOs) are one of...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jenny Lange, Haiyan Zhou, Amy McTague
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-06-01
Col·lecció:	Frontiers in Molecular Neuroscience
Matèries:	organoid cerebral organoid neurological disease antisense oligonucleotide (ASO) RNA therapeutics
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fnmol.2022.941528/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!